Funding for this research was provided by:
The Associated New Zealand ME Society
Otago Charitable Trust
Received: 3 September 2020
Accepted: 26 October 2020
First Online: 4 November 2020
Ethics approval and consent to participate
: This study was carried out under an ethics approval from the Southern Health and Disability Ethics Committee of New Zealand (ethics approval number 17/STH/188). All participants in this study provided informed written consents for participation in molecular studies from their donated blood samples, after viewing documentation about the studies.
: All participants in this study provided informed written consent for the results of the molecular studies they were involved in to be published.
: The authors declare they have no competing interests.